Cargando…
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
Whole-exome sequencing of cell-free DNA (cfDNA) could enable comprehensive profiling of tumors from blood but the genome-wide concordance between cfDNA and tumor biopsies is uncertain. Here we report ichorCNA, software that quantifies tumor content in cfDNA from 0.1× coverage whole-genome sequencing...
Ejemplares similares
-
Circulating Cell-Free DNA as Biomarker of Taxane Resistance in Metastatic Castration-Resistant Prostate Cancer
por: Francini, Edoardo, et al.
Publicado: (2021) -
Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair
por: Haradhvala, N. J., et al.
Publicado: (2018) -
Massively-parallel enrichment of minor alleles for mutational testing via low-depth duplex sequencing
por: Gydush, Gregory, et al.
Publicado: (2022) -
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy
por: Landau, Dan A., et al.
Publicado: (2017) -
Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens
por: Brastianos, Priscilla K., et al.
Publicado: (2017)